X-154428787-TGGCGGCGGCGGC-TGGCGGCGGCGGCGGCGGC

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001183.6(ATP6AP1):​c.111_116dupGGCGGC​(p.Ala38_Ala39dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,124,353 control chromosomes in the GnomAD database, including 1,267 homozygotes. There are 3,562 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.071 ( 735 hom., 2048 hem., cov: 21)
Exomes 𝑓: 0.0066 ( 532 hom. 1514 hem. )

Consequence

ATP6AP1
NM_001183.6 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.146

Publications

3 publications found
Variant links:
Genes affected
ATP6AP1 (HGNC:868): (ATPase H+ transporting accessory protein 1) This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
ATP6AP1-DT (HGNC:25138): (ATP6AP1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-154428787-T-TGGCGGC is Benign according to our data. Variant chrX-154428787-T-TGGCGGC is described in ClinVar as [Benign]. Clinvar id is 1165872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6AP1NM_001183.6 linkc.111_116dupGGCGGC p.Ala38_Ala39dup disruptive_inframe_insertion Exon 1 of 10 ENST00000369762.7 NP_001174.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6AP1ENST00000369762.7 linkc.111_116dupGGCGGC p.Ala38_Ala39dup disruptive_inframe_insertion Exon 1 of 10 1 NM_001183.6 ENSP00000358777.2 Q15904

Frequencies

GnomAD3 genomes
AF:
0.0710
AC:
7960
AN:
112046
Hom.:
735
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.247
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0271
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.000709
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00851
Gnomad NFE
AF:
0.00107
Gnomad OTH
AF:
0.0568
GnomAD2 exomes
AF:
0.00470
AC:
256
AN:
54469
AF XY:
0.00220
show subpopulations
Gnomad AFR exome
AF:
0.125
Gnomad AMR exome
AF:
0.00733
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000656
Gnomad OTH exome
AF:
0.00421
GnomAD4 exome
AF:
0.00662
AC:
6697
AN:
1012267
Hom.:
532
Cov.:
31
AF XY:
0.00465
AC XY:
1514
AN XY:
325735
show subpopulations
African (AFR)
AF:
0.249
AC:
5126
AN:
20599
American (AMR)
AF:
0.0107
AC:
243
AN:
22637
Ashkenazi Jewish (ASJ)
AF:
0.000177
AC:
3
AN:
16951
East Asian (EAS)
AF:
0.000249
AC:
6
AN:
24117
South Asian (SAS)
AF:
0.000498
AC:
23
AN:
46151
European-Finnish (FIN)
AF:
0.0000351
AC:
1
AN:
28515
Middle Eastern (MID)
AF:
0.0102
AC:
37
AN:
3620
European-Non Finnish (NFE)
AF:
0.000595
AC:
480
AN:
806952
Other (OTH)
AF:
0.0182
AC:
778
AN:
42725
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
260
521
781
1042
1302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0712
AC:
7978
AN:
112086
Hom.:
735
Cov.:
21
AF XY:
0.0594
AC XY:
2048
AN XY:
34460
show subpopulations
African (AFR)
AF:
0.247
AC:
7539
AN:
30541
American (AMR)
AF:
0.0270
AC:
292
AN:
10797
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3542
South Asian (SAS)
AF:
0.000356
AC:
1
AN:
2811
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6209
Middle Eastern (MID)
AF:
0.00935
AC:
2
AN:
214
European-Non Finnish (NFE)
AF:
0.00107
AC:
57
AN:
53116
Other (OTH)
AF:
0.0561
AC:
86
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
217
434
651
868
1085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00185
Hom.:
1

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Nov 19, 2021
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.15
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781797236; hg19: chrX-153657133; COSMIC: COSV62341026; API